drugset / Trial / NCT01834508
3E Extension Study
Phase 4
Unknown
600 enrolled
Nanfang Hospital, Southern Medical University
Major Science and Technology Special Project of China 12th Five-year · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term efficacy and safety of entecavir 0.5 mg/d + adefovir 10 mg/d for treatment experienced chronic hepatitis B patients.
Timeline
- Start
- 2013-03
- Primary completion
- 2016-06
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adefovir | Unknown | 10 mg | — |
| Subject | Entecavir | Small molecule | 0.5 mg | Oral |